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In resource-limited countries, nosocomial transmission of bloodborne pathogens is a major
public health concern. After a major outbreak of human immunodeficiency virus (HIV) in-
fection in ∼400 children in 1998 in Libya, we tested HIV, hepatitis C virus (HCV), and hepatitis
B virus (HBV) markers in 148 children and collected epidemiological data in a subgroup of
37 children and 46 parents. HIV infection was detected in all children but one, with HCV or
HBV coinfection in 47% and 33%, respectively. Vertical transmission was ruled out by analysis
of parents’ serology. The children visited the same hospital 1–6 times; at each visit, invasive
procedures with potential blood transmission of virus were performed. HIV and HCV geno-
typic analyses identified a HIV monophyletic group, whereas 4 clusters of HCV sequences
were identified. To our knowledge, this is the largest documented outbreak of nosocomial
HIV transmission.
Transmission of bloodborne viral pathogens through inva-
sive medical procedures has been long recognized [1]. In in-
dustrialized countries, invasive medical procedures were major
routes of pathogenic spread until some decades ago [2], and
occasional nosocomial outbreaks are still reported [3, 4]. In
countries with limited health care resources, the higher preva-
lence of parenterally transmissible pathogens, the overuse of
injections, the frequent sharing of syringes, and the poor en-
forcement of safety guidelines are associated with frequent out-
breaks of bloodborne pathogens [1, 5]. In these countries, chil-
dren are at higher risk because of their frequent use of medical
facilities and because of the paucity of symptoms in most pa-
tients during acute human immunodeficiency virus (HIV),
hepatitis C virus (HCV), or hepatitis B virus (HBV) infection.
The Libyan representative of the Word Health Organization
(WHO) alerted us of the occurrence of ∼400 recent cases of
HIV infection among children attending the Pediatric Depart-
ment of Al-Fateh Hospital (Benghazi, Libya) in 1998 and asked
us to perform in-depth investigations on 111 coded plasma
Received 26 January 2001; revised 6 April 2001; electronically published 10
July 2001.
Informed parental consent was obtained, and ethical committees approved
the investigation.
Financial support: Swiss National AIDS Research Program (grant
3200.56.059.98); Swiss National Science Foundation (grant 32–52193.97); Lib-
yan government.
Reprints or correspondence: Dr. Luc Perrin, Laboratory of Virology,Geneva
University Hospital, 1211 Geneva 14, Switzerland (luc.perrin@hcuge.ch).
The Journal of Infectious Diseases 2001;184:369–72
 2001 by the Infectious Diseases Society of America. All rights reserved.
0022-1899/2001/18403-0018$02.00
samples and on a group of infected children referred to us. Our
investigation was limited to virological analysis and to the col-
lection of basic epidemiological data, because we did not have
the opportunity to complete our investigation by a field study.
Methods
Study participants. All children were treated at the Al-Fateh
Hospital, where the first case of HIV infection was detected in May
1998. In September 1998, 111 coded plasma samples from HIV-
infected children were provided to us. Epidemiological data were
collected in a group of 37 children and 46 of their parents referred
to the Geneva and Lausanne University Hospital by the Libyan
government in April 1999.
Serology. Anti-HIV, anti-HCV, anti–hepatitis B core antigen
(HBcAg), anti–hepatitis B surface antigen (anti-HBsAg), and hepa-
titis B surface antigen (HBsAg; Axsym) were measured in plasma
samples. HIV infection was confirmed by means of Western blot
(Cambridge Biotech).
HIV-1 and HCV viremia. HIV-1 and HCV RNA were quanti-
tated with Cobas Amplicor Monitor (Roche).
HIV-1 amplification and sequencing. HIV RNA was extracted
from plasma and was reverse-transcribed with random primers, as
described elsewhere [6]. The p17 region of the gag gene (nt 836–1270
of HXB2R [7]), the protease (PR) region (nt 1918–2735) and the
reverse-transcriptase (RT) region of the pol gene (nt 2586–3266),
and the C2V3 region of the env gene (nt 6950–7367) were amplified,
as reported elsewhere [6, 8]. Direct sequencing was performed with
the Big Dye Terminator kit on an automated sequencer (model
377; Applied Biosystems).
HCV genotyping. HCV genotyping was performed by means of
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Table 1. Human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV) serology





HIV-HCV-HBVbEIA WB Anti-HBcAg Anti-HBsAg HBsAg
Coded plasma samples 111 99 96 49 31 56 ND 22
Children referred to us 37 100 100 43 33 59 3 17
Parentsc 46 2 2 4 26 22 2 0
NOTE. Data are percentages, unless otherwise noted. HBcAg, hepatitis B core antigen; HBsAg, hepatitis B surface antigen;
ND, not done; WB, Western blot.
a Anti-HCV–positive antibodies or HCV RNA–positive and anti-HCV–negative antibodies (3 coded plasma samples).
b Anti-HIV–positive and anti-HCV–positive antibodies or HCV RNA–positive and anti-HBcAg-positive antibodies.
c A total of 25 mothers and 21 fathers.
a commercial assay (INNO–line probe assay HCV II; Innogenetics
N.V.).
HCV E2 amplification and sequencing. Total RNA was ex-
tracted from plasma and was reverse transcribed. The hypervari-
able region 1 of the envelope glycoprotein E2 (nt 952–1365) was
amplified with primers specific for genotypes 1 and 4 (5′-ATG-
GCNTGGGAYATGATGATGAAYTGG-3′ and 5′-CCGYTCG-
GRRCASCCTGARSWGTTRAAYTTGT-3′) [9], which was fol-
lowed by a nested polymerase chain reaction (PCR) with primers
5′-GGNGGBCACTGGGGHRTYCT-3′ and 5′-ATRTGCCARC-
TSCCRTTGSTGTTGA-3′ (nt 1048–1265). Each round of PCR
consisted of a 5-min hot start at 95C, followed by 35 cycles with
a denaturation step at 94C for 30 s, an annealing step at 55C for
45 s, an elongation step at 72C for 45 s, and a last extension step
at 72C for 7 min. Direct sequencing was performed with the prim-
ers used for the nested PCR.
Phylogenetic analysis. Sequences encompassing bp 861–1246,
bp 2252–2549, bp 2634–3223, and bp 6958–7281 of the HIV
HXB2R strain [7] and bp 1068–1240 of HCV [9] were aligned by
means of Clustal W version 1.7 [10]. Phylogenetic analyses were
carried out by using the PHYLIP software package [11]. Evolu-
tionary distances were estimated with the DNADIST program.
Trees with all branch lengths drawn to scale were constructed by
the NEIGHBOR program.
Results
Epidemiological data. According to the Libyan WHO rep-
resentative, 393 children were infected with HIV in 1998 at the
Pediatric Department of Al-Fateh Hospital. Appropriate mea-
sures were implemented in 1999 to stop this outbreak, including
the use of disposable injection material. A detailed history,
which was collected from the 37 children and the 46 parents
referred to us, revealed that all these children had been seeking
medical care as outpatients ( ) or had been hospitalizednp 14
( ) at the Al-Fateh Hospital. The mean number of visitsnp 27
from January 1998 through April 1999 was 2.14 visits (range,
1–4 visits) for outpatients and 1.56 visits (range, 1–6 visits) for
hospitalized patients. All children had invasive procedures for
blood collection, and most of them had a venous line. Vacci-
nation history was documented for all children; 83% had been
vaccinated against HBV during the first 6 months of life.
Serological analysis in children and parents. The data on
the 111 coded plasma collected in September 1998 are reported
in table 1. HIV antibodies were detected in 99%, and HIV-1
infection was confirmed by Western blot (at least 1 positive
band for both env and gag components) in 96%. Two samples
without antibodies were positive for HIV-1 RNA. Twenty chil-
dren had a Western blot pattern suggestive of primary HIV
infection (!4 reactive bands).
Anti-HCV was detected in 46% of the plasma samples. HCV
RNA was detected in 3 of 5 anti-HCV–negative samples from
patients with recent HIV infection (!4 positive bands on West-
ern blot), which suggests HIV-HCV coinfection in some of the
children. Anti-HBsAg, anti-HBcAg, or both were detected in
56%, 31%, and 12.5%, respectively, of the plasma samples. Eigh-
teen percent of the samples had anti-HBcAg without anti-
HBsAg. The small amount of plasma available precluded a
systematic dosage of HBsAg. Overall, 22% of the children were
coinfected or had been infected with HIV, HCV, or HBV.
Table 1 also reports the serological data from the groups of
37 children and 46 parents referred to us. The mean age of these
children was 4.1 years (range, 0.7–15.8 years). HIV-1 infection
was confirmed by Western blot. Anti-HCV antibodies were de-
tected in 43%. Anti-HBsAg and anti-HBcAg were detected in
59% and 33% of the plasma samples, respectively. Eleven percent
of the study group had anti-HBcAg without anti-HBsAg. Of the
31 children vaccinated against HBV during the first 6 months of
life, 6 had both anti-HBsAg and anti-HBcAg antibodies. HBV
serology was available from the mothers of 3 of them; none were
positive for HBsAg or had isolated anti-HBcAg. The prevalence
of HCV and HBV serological markers in this group of children
was similar to that of the coded plasma group.
The parent’s serology (25 mothers and 21 fathers) revealed
that only 1 mother was positive for anti–HIV and that 2 parents
were positive for anti–HCV (the mother of a anti-HCV–nega-
tive child and 1 father). Anti-HBcAg was detected in 26% of the
parents, and all but one (HBsAg positive) had anti-HBsAg.
Genetic characterization of HIV. HIV sequences were de-
termined in 36 children. Neighbor-joining trees including these
sequences and reference sequences of HIV-1 group M (subtypes
A, B, C, D, G, and CRF02_ A/G) revealed that sequences from
children form a monophyletic group with bootstrap values
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Figure 1. A, Phylogenetic trees constructed from human immuno-
deficiency virus type 1 (HIV-1) p17 gag sequences from 36 children.
Phylogenetic analysis was carried out by using PHYLIP software package
[11]. Bootstrap scores 1700 (70% of 1000 replicates) are shown. Reference
sequences from 5 HIV-1 (U455-A, HXBR-B, 92BR25-C, ELI-D, and
92NG083-G) and 1 circulating recombinant form (CRF02_ A/G) group
M subtypes are reported. B, Phylogenetic trees constructed from hepatitis
C virus (HCV) E2 envelope glycoprotein sequences from 15 Libyan chil-
dren. Phylogenetic analysis of the HCV E2 encoding region, which was
carried out by using the PHYLIP package, was based on comparison of
representative nucleotide sequences from HCV genotypes 1a, 1b, 2, and
4a and the 15 children’s isolates [11]. Bootstrap scores 1700 (70% of
1000 replicates) are shown. Four different clusters are observed, which
are composed of 8 isolates in cluster 1, 1 isolate in cluster 2, and 3 iso-
lates in clusters 3 and 4. Clusters 1–3 are genotype 4, and cluster 4 is
genotype 1a.
1997/1000 for the 4 HIV genes analyzed (p17, PR, RT, and
C2V3; figure 1A, tree of p17; others not shown). These se-
quences were related closely to an isolate from a Djibouti pa-
tient, IbNAG, prototype of the circulating recombinant form
CRF02_ A/G. No sequence was recovered from the HIV-in-
fected mother (!400 HIV RNA copies/mL).
A pairwise comparison was performed for the 4 genes ana-
lyzed; the mean variation was 1.06% (range, 0%–2.4%) for p17,
0.21% (range, 0%–1.7%) for PR, 1.11% (range, 0%–3.7%) for
RT, and 3.19% (range, 0%–8.7%) for C2V3. A GPGQ motif in
the V3 loop was found in all children. We found no mutations
associated with drug resistance.
Genetic characterization of HCV. HCV typing was per-
formed for 27 children; 17 had subtype 4c/4d, and 10 had sub-
type 1a. HCV subtypes of the HCV-infected mother and of the
HCV-infected father were 4c/4d and 4, respectively. HCV se-
quences were determined in 15 HCV RNA–positive children
on the envelope glycoprotein E2 and were used to generate a
neighbor-joining tree (figure 1B). Isolates fell into 4 clusters: 8
in cluster 1 (6415, 4702, 4449, 7300, C03, C04, 7273, and A33),
1 in cluster 2 (A32), 3 in cluster 3 (B01, 6529, and 3082), and
3 in cluster 4 (6534, C02, and 3205). Clusters 1, 2, and 3 be-
longed to genotype 4, and cluster 4 belonged to genotype 1a.
The mean pairwise comparison of Libyan isolates within the
E1/E2 region sequences showed an average intracluster varia-
tion of 5.7% (range, 1.7%–9.2%), 2.7% (range, 1.7%–3.5%), and
1.1% (range, 0%–1.7%), respectively, for clusters 1, 3, and 4.
The intercluster nucleotide variation ranged from 25.0% (cluster
2 vs. cluster 3) to 42.4% (cluster 3 vs. cluster 4).
Discussion
Recent modeling suggests that ∼8–16 million HBV, 2.3–4.7
million HCV, and 80,000–160,000 HIV infections occur yearly
through unsafe injections worldwide, mostly in resource-limited
countries [1]. In this latter setting, our study reports the largest
outbreak of nosocomial transmission of HIV infection asso-
ciated with a high incidence of HCV and HBV transmission.
Our investigation was limited by the lack of access to a field
study, which could have provided more detailed epidemiological
informations. However, the nosocomial origin of HIV infection
is supported by the monotypic characteristic of the HIV se-
quences. The interisolate variation for the p17 gag region among
Libyan children (0%–2.4%) was lower than the 4.5%–17% re-
ported elsewhere for unrelated isolates [12]. Higher interisolate
variation was observed for the C2V3 region (0%–9%), which
probably reflects a higher substitution rate due to immune pres-
sure, but this variability corresponds to that reported for related
samples within sexual or parenteral transmission [13].
However, these genetic data should be interpreted with cau-
tion, because, during the rapid spreading of HIV, low variation
among HIV strains of unrelated infected people has been re-
ported [14]. Other arguments support the nosocomial origin of
this outbreak: all children attended the Pediatric Department
of the same hospital and underwent invasive procedures; the
serological data of a subgroup of parents exclude vertical trans-
mission; there is a high incidence of concomitant HIV, HCV,
and even HBV infection, despite an active HBV vaccination
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program; and evidence suggests that some children were coin-
fected with HIV and HCV during the same invasive procedure.
The low HIV interisolate variation contrasts with the detec-
tion of 4 HCV clusters. This observation is consistent with the
very low prevalence of HIV infection, compared with the high
prevalence of HCV infection in Libya and neighboring Egypt;
this could, in turn, result in multiple entries of HCV but not
of HIV [5, 15]. The most likely scenario is that a first child was
infected with HIV through contaminated injection material or
through an unidentified vertical transmission. Injection material
contaminated by his blood then generated the spread of HIV
infection. Ongoing acute primary HIV infection, with several
children carrying very high viremia, then would have contrib-
uted to the explosive spread of HIV infection. Consistent with
this hypothesis, 20 children had a Western blot profile consistent
with primary HIV infection in 1998, and 4 of the children
referred to us had a viremia 1106 HIV-1 RNA copies/mL (data
not shown). Finally, the selection of the children’s population,
which was based on a positive HIV serology, did not exclude
a much larger parallel outbreak of HCV infection, which should
be investigated.
The spreading of HBV infection probably was limited by the
high percentage of children vaccinated in the first 6 months of
life. However, evidence of HBV infection, which was based on
detection of anti-HBcAg antibodies, was present in 33% of
children. More importantly, the plasma samples of 6 children,
who were vaccinated before the age of 6 months, contained
both anti-HBsAg and anti-HBcAg antibodies. Because vertical
transmission was ruled out for 3 of them, their serological pat-
tern is thus consistent with an HBV contamination during or
close to the administration of the HBV vaccine.
Detection of this large outbreak was possible though the com-
mitment of the Libyan authorities to assess its extension and to
stop it. It underlines the necessity to invest in education programs
for health care workers and to enforce safe medical practices.
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